PurchasingPolicy.orgPURCHASINGPOLICYBETA
← Back to Influence Map
Entity DossierOrganization

PRIME THERAPEUTICS

MN · US

pharmaceuticals

Tracked direct giving

$0

Tracked donations to candidate

$0

LDA reported lobbying spend

$50,000

Connections

4

Lobbying Activity Detail

Disclosed lobbying expenditures from LDA filings where this entity is the client. Dollar amounts represent what was reported to the Senate Office of Public Records.

Top Lobbying Issues

HCRHealth Issues
$270K
MMMMedicare/Medicaid
$190K
PHAPharmacy
$80K

Lobbying Firms Retained

PRIME THERAPEUTICS$160K
STUMPTOWN STRATEGIES$80K
GOVERNMENT COUNSEL, LLC$30K

Bills Referenced in Lobbying Filings

PBM

Lobbying data from Senate LDA filings and the LobbyView dataset (MIT/NSF, CC-BY-4.0). Dollar figures represent disclosed expenditures only and may not capture all influence activity. Issue codes follow the LDA general issue classification.

Connection Graph
0 nodes · 0 edgesHover for labels · Double-click to expand
Loading graph...
Person
Organization
PAC
Gov Body
Legislature
Think Tank
Industry
Outcome

Click a node to see details

Double-click to expand its connections

Relationships

TypeConnected ToDetailsSource
Employed byGOVERNMENT COUNSEL, LLCHired GOVERNMENT COUNSEL, LLC to lobby on PharmaceuticalsSource
Employed bySTUMPTOWN STRATEGIESHired STUMPTOWN STRATEGIES to lobby on PharmaceuticalsSource
Lobbied forPharmacy Benefit Manager Reform ActLDA filing: lobbied on PBM Reform Act, period 1st Quarter (Jan 1 - Mar 31), reported amount $20,000Source
Lobbied forAction to Delay Effective Date Consistent With Congressionally Enacted MoratoriumLobbied on pbm — matched LDA filing topic to Federal Register rule.Source